ZA200804163B - New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions - Google Patents

New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions

Info

Publication number
ZA200804163B
ZA200804163B ZA200804163A ZA200804163A ZA200804163B ZA 200804163 B ZA200804163 B ZA 200804163B ZA 200804163 A ZA200804163 A ZA 200804163A ZA 200804163 A ZA200804163 A ZA 200804163A ZA 200804163 B ZA200804163 B ZA 200804163B
Authority
ZA
South Africa
Prior art keywords
derivatives
basis
pharmaceutical compositions
new adjuvants
bisacyloxypropylcysteine
Prior art date
Application number
ZA200804163A
Other languages
English (en)
Inventor
Ebensen Thomas
Morr Michael
Carlos A Guzman
Original Assignee
Helmholtz Infektionsforschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Infektionsforschung filed Critical Helmholtz Infektionsforschung
Publication of ZA200804163B publication Critical patent/ZA200804163B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/14—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200804163A 2005-11-22 2006-11-22 New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions ZA200804163B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05025431A EP1787660A1 (fr) 2005-11-22 2005-11-22 Nouveaux adjuvants a base des conjugés de bisacyloxypropylcystéine et leurs utilisations en compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
ZA200804163B true ZA200804163B (en) 2009-10-28

Family

ID=35787974

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804163A ZA200804163B (en) 2005-11-22 2006-11-22 New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions

Country Status (11)

Country Link
US (1) US8119689B2 (fr)
EP (2) EP1787660A1 (fr)
JP (1) JP5249041B2 (fr)
KR (1) KR20080069267A (fr)
CN (1) CN101360514A (fr)
AU (1) AU2006316791B2 (fr)
BR (1) BRPI0618847A2 (fr)
CA (1) CA2628736A1 (fr)
EA (1) EA200801411A1 (fr)
WO (1) WO2007059931A1 (fr)
ZA (1) ZA200804163B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2196196A1 (fr) * 2008-12-10 2010-06-16 Medipol S.A. Composé, médicament, composition de vaccin et nanocapsules
EP2305283A1 (fr) 2009-09-24 2011-04-06 Helmholtz-Zentrum für Infektionsforschung GmbH Compositions pharmaceutiques pour traiter les maladies inflammatoires dérégulées
WO2011138050A1 (fr) 2010-05-07 2011-11-10 Helmholtz-Zentrum für Infektionsforschung GmbH Procédé de vaccination
CA2800424C (fr) * 2010-06-04 2018-10-23 Inserm (Institut National De La Sante Et De La Recherche Medicale) Compose de beta glucan cyclique b1,2 destine a ameliorer l'immunite adaptative par activation de cellules dendritiques
CN103154251A (zh) * 2010-09-30 2013-06-12 佛兰瓦克斯有限责任公司 病毒体颗粒的生产
CA2938626A1 (fr) 2013-07-26 2015-01-29 John Rothman Compositions permettant d'ameliorer l'avantage therapeutique du bisantrene
CN105126092A (zh) * 2015-09-30 2015-12-09 青岛农业大学 一种以壳寡糖为佐剂负载大肠杆菌菌毛黏附素的鸭疫里默氏菌菌影疫苗的制备方法及其应用
CA3094072A1 (fr) * 2018-03-15 2019-09-19 Atossa Therapeutics, Inc. Procedes in situ d'induction de reponse immunitaire
US20220388950A1 (en) * 2019-06-26 2022-12-08 Axelia Oncology Pty Ltd Novel molecules
CN112826928A (zh) * 2020-11-20 2021-05-25 郑州大学 一种cd40靶向树突状细胞纳米疫苗及其构建方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2307958T3 (es) 2002-04-04 2008-12-01 Helmholtz-Zentrum Fur Infektionsforschung Gmbh Uso de un lipopeptido o una lipoproteina como adyuvante en la vacunacion terapeutica o profilactica.
EP1382352A1 (fr) 2002-07-19 2004-01-21 GBF Gesellschaft für Biotechnologische Forschung mbH Conjugués de bisacylpropylcystéine et leur utilisation
JP4412461B2 (ja) * 2002-11-20 2010-02-10 日油株式会社 修飾された生体関連物質、その製造方法および中間体
ES2562456T3 (es) * 2003-03-24 2016-03-04 Valneva Austria Gmbh Uso de un adyuvante que induce una respuesta inmune Th1 para mejorar las respuestas inmunes
DE10326303A1 (de) 2003-06-11 2004-12-30 Celares Gmbh Reagenzien zur Modifikation von Biopharmazeutika, deren Herstellung und Anwendung

Also Published As

Publication number Publication date
WO2007059931A1 (fr) 2007-05-31
CA2628736A1 (fr) 2007-05-31
AU2006316791A1 (en) 2007-05-31
KR20080069267A (ko) 2008-07-25
EP1973571A1 (fr) 2008-10-01
CN101360514A (zh) 2009-02-04
JP2009517350A (ja) 2009-04-30
WO2007059931A8 (fr) 2007-07-19
EP1787660A1 (fr) 2007-05-23
AU2006316791B2 (en) 2012-07-12
US8119689B2 (en) 2012-02-21
BRPI0618847A2 (pt) 2011-10-04
JP5249041B2 (ja) 2013-07-31
EA200801411A1 (ru) 2008-10-30
US20090017106A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
HK1121396A1 (en) Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions pqs
IL190292A (en) History of pyridopyrimidinone and their pharmaceutical preparations
IL189782A (en) The history of sulfonylpyrol and its medicinal products and their use
ZA200804163B (en) New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions
IL191140A0 (en) Aminopyrimidine derivatives and pharmaceutical compositions containing the same
IL188941A0 (en) Pyrazinolyguanidine derivatives and pharmaceutical compositions containing the same
IL186738A0 (en) Pyrizole derivatives and pharmaceutical compositions containing the same
PL1861387T3 (pl) Pochodne benzoimidazolu i ich kompozycje farmaceutyczne
IL183919A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
IL184783A0 (en) Aminopyridine derivatives and pharmaceutical compositions containing the same
EP1890677A4 (fr) Compositions pharmaceutiques et leur utilisation
IL188050A0 (en) Azaindazole derivatives and pharmaceutical compositions containing the same
IL189187A (en) Polymeric couplings of a252-k and their history, their pharmaceutical preparations and their uses
IL193240A0 (en) Dihydrodiazepine derivatives and pharmaceutical compositions containing the same
IL189697A0 (en) Pyridazinone derivatives and pharmaceutical compositions containing the same
IL190249A0 (en) Deazapurine derivatives and pharmaceutical compositions containing the same
IL177168A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
IL180762A (en) Oligomer-insulin conjugates, formulations containing them and their use
IL183102A0 (en) Betulin derivatives and pharmaceutical compositions containing the same
IL203915A (en) Annotations of 2-Benzylphenyl-6-Hydroxymethyl-Tetrahydro-2 H-Pyrene-3,4,5-Triol
IL196601A0 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
IL194460A0 (en) Deazapurine derivatives and pharmaceutical compositions containing the same
IL194429A0 (en) Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
PT1861387E (pt) Derivados de benzimidazol e composições farmacêuticas dos mesmos
IL221323A0 (en) 1-methyl-1h- pyridin-2-one- phenanthridine derivatives and pharmaceutical compositions containing the same